NewYork-Presbyterian has named Dr. Laureen Hill senior vice president and chief operating officer of NewYork-Presbyterian/Columbia University Irving Medical Center, effective the end of October. She joins from Emory Healthcare, where she held several key leadership roles.
|
||||||||
“We are pleased to welcome Dr. Hill to NewYork-Presbyterian,” said Dr. Steven J. Corwin, president and CEO of NewYork-Presbyterian. “She is a nationally renowned leader in academic medicine who will be instrumental in accomplishing our goals for advancing NewYork-Presbyterian/Columbia University Irving Medical Center’s exceptional care.”
“Dr. Hill has a long track record of success in strategic planning and delivering high quality care in an academic setting,” said Dr. Laura L. Forese, executive vice president and chief operating officer of NewYork-Presbyterian. “We expect her to have a transformative impact on research, education and care at NewYork-Presbyterian/Columbia.”
As senior vice president and chief operating officer, Dr. Hill will manage and direct daily operations, including the cost, quality and delivery of services for NewYork-Presbyterian’s world-class centers in northern Manhattan. NewYork-Presbyterian/Columbia and NewYork-Presbyterian Allen Hospital offer high quality, innovative care across nearly every area of medicine, provided by physicians from Columbia University Medical Center. Dr. Hill will work closely with Paul Dunphey, chief operating officer of NewYork-Presbyterian Allen, to continue to advance care at the Inwood campus, which is home to The Spine Hospital, an internationally recognized center for spine care.
Dr. Hill has more than 17 years of leadership in academic healthcare, with experience in setting strategic direction, developing clinical programs and leading culture and change management. Most recently, Dr. Hill served as chair of the Department of Anesthesiology and chief of anesthesia services for Emory Healthcare, as well as chair of Emory’s IT Governance Committee and co-chair of its Perioperative Governance Committee. Prior to joining Emory, she was the vice chair of the Department of Anesthesiology at Washington University School of Medicine and a professor of anesthesiology and cardiothoracic surgery.
A board certified anesthesiologist, she received her medical degree from the University of California, Davis, and holds an M.B.A. from Washington University. She completed her residency in anesthesia at Stanford University, as well as fellowships in critical care medicine and adult and pediatric cardiovascular anesthesia. Dr. Hill is a member of numerous national and international committees, including the Society of Critical Care Anesthesiologists, the Society of Critical Care Medicine and the Society of Academic Anesthesiology Association.
NewYork-Presbyterian
NewYork-Presbyterian is one of the nation’s most comprehensive, integrated academic healthcare delivery systems, whose organizations are dedicated to providing the highest quality, most compassionate care and service to patients in the New York metropolitan area, nationally, and throughout the globe. In collaboration with two renowned medical schools, Weill Cornell Medicine and Columbia University Medical Center, NewYork-Presbyterian is consistently recognized as a leader in medical education, groundbreaking research and innovative, patient-centered clinical care.
NewYork-Presbyterian has four major divisions:
- NewYork-Presbyterian Hospital is ranked #1 in the New York metropolitan area by U.S. News and World Report and repeatedly named to the Honor Roll of “America’s Best Hospitals.”
- NewYork-Presbyterian Regional Hospital Network comprises hospitals and other facilities in the New York metropolitan region.
- NewYork-Presbyterian Physician Services, which connects medical experts with patients in their communities.
- NewYork-Presbyterian Community and Population Health, encompassing ambulatory care network sites and community healthcare initiatives, including NewYork Quality Care, the Accountable Care Organization jointly established by NewYork-Presbyterian Hospital, Weill Cornell Medicine and Columbia.
For more information, visit www.nyp.org and find us on Facebook, Twitter and YouTube.
###
Attachments:
A photo accompanying this announcement is available at http://www.globenewswire.com/NewsRoom/AttachmentNg/530222dc-731d-49cc-970e-e2430c289ad8
Attachments:
A photo accompanying this announcement is available at http://www.globenewswire.com/NewsRoom/AttachmentNg/db03eca3-afd0-47a8-81fe-0ca493f93929
Office of Public Affairs NewYork-Presbyterian 212-821-0560 [email protected]


Roche CEO Warns US Drug Price Deals Could Raise Costs of New Medicines in Switzerland
Niigata Set to Approve Restart of Japan’s Largest Nuclear Power Plant in Major Energy Shift
Citi Appoints Ryan Ellis as Head of Markets Sales for Australia and New Zealand
Trump Signals Push for Lower Health Insurance Prices as ACA Premium Concerns Grow
TikTok U.S. Deal Advances as ByteDance Signs Binding Joint Venture Agreement
Italy Fines Apple €98.6 Million Over App Store Dominance
U.S. Lawmakers Urge Pentagon to Blacklist More Chinese Tech Firms Over Military Ties
Moore Threads Unveils New GPUs, Fuels Optimism Around China’s AI Chip Ambitions
Delta Air Lines President Glen Hauenstein to Retire, Leaving Legacy of Premium Strategy
FedEx Beats Q2 Earnings Expectations, Raises Full-Year Outlook Despite Stock Dip
Google and Apple Warn U.S. Visa Holders to Avoid International Travel Amid Lengthy Embassy Delays
Elon Musk Wins Reinstatement of Historic Tesla Pay Package After Delaware Supreme Court Ruling
Harris Associates Open to Revised Paramount Skydance Bid for Warner Bros Discovery
Nike Shares Slide as Margins Fall Again Amid China Slump and Costly Turnaround
JPMorgan’s Top Large-Cap Pharma Stocks to Watch in 2026
FDA Fast-Tracks Approval of Altria’s on! PLUS Nicotine Pouches Under New Pilot Program
AstraZeneca’s LATIFY Phase III Trial of Ceralasertib Misses Primary Endpoint in Lung Cancer Study 



